The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraven House Capital Regulatory News (CRV)

Share Price Information for Craven House Capital (CRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.20
Bid: 0.15
Ask: 0.25
Change: 0.00 (0.00%)
Spread: 0.10 (66.667%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.20
CRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Changes

4 Oct 2016 07:00

RNS Number : 5670L
Craven House Capital PLC
04 October 2016
 

4 October 2016

 

 

 Craven House Capital plc

 

("Craven House" or the "Company")

 

Board Changes

 

Craven House Capital (AIM:CRV) announces that Mr. Richard Burrows has been appointed to the Board of the Company as Chairman with immediate effect. Acting Chairman, Mr. Mark Pajak, will remain on the Board as Non-Executive Director.

 

Mr. Burrows brings considerable experience to the Board, having spent over 35 years leading successful businesses in a diverse range of sectors from consumer goods to banking and financial services and will offer the benefit of extensive international experience in both developed and emerging markets. Mr. Burrows is currently Chairman of British American Tobacco Plc and Non-Executive Director at Rentokil Initial Plc and Carlsberg A/S.

 

Outgoing Chairman, Mark Pajak commented, "Craven House Capital shareholders are fortunate to have such a seasoned professional as Chairman as we continue to grow the Company. Mr. Burrows' extensive experience in our target markets and his relationships will be invaluable to the Company."  

 

Mr. Burrows commented, "I am very pleased to join the Board of Craven House Capital. The Company's philosophy and strategy should provide an exciting opportunity for shareholders and I look forward to working with the Board and management to expand and grow the business."

 

Mr. Burrows is a qualified accountant. His executive career has been with Irish Distillers, where he was Chief Executive from 1978 to 2000 and at Pernod Ricard, where he was Co-Chief Executive from 2000 to 2005. He has been Chairman of British American Tobacco since 2009 and prior to that served as director, then Governor, of Bank of Ireland from 2000 to 2009.

 

Information in respect of Mr. Burrows as required by Schedule 2(g) of the AIM Rules for Companies is included below.

~ Ends ~

 

 

For further information please contact:

 

Craven House Capital Plc

Mark Pajak

www.Cravenhousecapital.com

 

Tel: 020 7002 1027

 

SI Capital

Broker

Nick Emerson

www.sicapital.co.uk

Tel: 01483 413500

 

SPARK Advisory Partners Limited

Nominated Adviser

Matt Davis/Mark Brady

www.Sparkadvisorypartners.com

 

Tel: 0203 368 3550

 

 

Additional information on Richard Burrows:

 

Full name: Richard George William Burrows

Age: 70

 

Current Directorships / Partnerships:

British American Tobacco PLC

Carlsberg AS

Rentokil Initial PLC

 

Previous Directorships / Partnerships in the last 5 years:

Eurasian Natural Resources Corporation Limited

Voicesage Global Holdings Ltd.

 

There is no further information required to be disclosed in respect of the above appointment pursuant to Schedule 2(g) of the AIM Rules for Companies.

 

About Craven House Capital:

 

Craven House Capital is a frontier and emerging market focused merchant bank seeking value oriented long term investments. Craven House invests in all segments of the capital structure in partnership with local entrepreneurs and the local business community. Craven House provides long term patient capital and is often involved in restructuring, expansion and turn around investments in crisis and transitioning economies.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFSEFWDFMSEFS
Date   Source Headline
26th Sep 20072:00 pmRNSTrading Statement
10th Aug 20077:01 amRNSAIM Rule 26
21st Jun 20077:01 amRNSJoint Venture
19th Jun 20073:52 pmRNSIssue of Warrants
14th Jun 200711:37 amRNSResult of AGM
14th Jun 20077:01 amRNSAGM Statement
31st May 20071:00 pmRNSTotal Voting Rights
31st May 200712:30 pmRNSIssue of Equity
31st May 200712:00 pmRNSRelated Party Transactions
25th Apr 20072:42 pmRNSTrading Update
11th Apr 200711:20 amRNSHolding(s) in Company
22nd Mar 20077:02 amRNSFinal Results
19th Mar 20078:00 amRNSNotice of Results
11th Dec 200611:51 amRNSTotal Voting Rights
26th Oct 20067:01 amRNSProperty Development
27th Sep 20067:01 amRNSInterim Results
31st Jul 20067:01 amRNSSaga Contract
10th Jul 20067:00 amRNSItalian Contract Update
4th Jul 200610:58 amRNSChange of Adviser
16th Jun 20064:13 pmRNSResult of AGM
16th Jun 20067:00 amRNSAGM Statement
17th May 20067:00 amRNSReport and Accounts Posted
25th Apr 20062:48 pmRNSProgress in First Quarter
6th Apr 20066:24 pmRNSDirector/PDMR Shareholding
6th Apr 20068:00 amRNSPreliminary Results
22nd Feb 20063:46 pmRNSShare price movement
16th Dec 200512:25 pmRNSChange of Registered Office
23rd Nov 20057:00 amRNSExpansion into Cyprus, Turkey
28th Oct 20058:00 amRNSBusiness Update
29th Sep 20054:47 pmRNSInterim Results
4th Jul 20057:00 amRNSProperty Development
15th Jun 200511:00 amRNSAGM Statement
20th May 200512:59 pmRNSAnnual Report and Accounts
16th May 20059:00 amRNSBusiness Update
21st Apr 200512:42 pmRNSTrading Statement
21st Mar 20059:38 amRNSFinal Results
3rd Mar 20054:39 pmRNSNotice of Prelimnary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.